We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-16.09%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.65B
AUM Growth
-$1.07B
(-39%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-29.24%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
77
New
–
Increased
10
Reduced
34
Closed
14
Top Buys
| 1 |
Replimune Group
REPL
|
+$12.8M |
| 2 |
Cogent Biosciences
COGT
|
+$6.35M |
| 3 |
Establishment Labs
ESTA
|
+$5.01M |
| 4 |
Annexon
ANNX
|
+$4.78M |
| 5 |
Intuitive Surgical
ISRG
|
+$4.1M |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$83.3M |
| 2 |
Krystal Biotech
KRYS
|
+$81.8M |
| 3 |
Abbott
ABT
|
+$29.8M |
| 4 |
Align Technology
ALGN
|
+$28.6M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$27.3M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LVTX
51
DELISTED
LAVA Therapeutics
LVTX
| $3.73M | 0.23% |
2,074,372
| – | – |
|
52
Invivyd
IVVD
$241M
| $3.37M | 0.2% |
3,065,714
+1,624,989
| +113% | +$3.59M |
|
53
Cabaletta Bio
CABA
$452M
| $3.31M | 0.2% |
442,826
| – | – |
|
|
GRTS
54
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.16M | 0.19% |
5,107,732
-647,343
| -11% | -$547K |
|
|
ALLK
55
DELISTED
Allakos
ALLK
| $3.08M | 0.19% |
3,077,828
-373,248
| -11% | -$443K |
|
56
Xeris Biopharma Holdings
XERS
$1.5B
| $2.35M | 0.14% |
1,046,587
| – | – |
|
|
RAPT
57
DELISTED
RAPT Therapeutics
RAPT
| $1.64M | 0.1% |
67,085
-15,715
| -19% | -$726K |
|
|
KLRS
58
Kalaris Therapeutics
KLRS
$115M
| $1.38M | 0.08% |
82,955
| – | – |
|
|
ACHL
59
DELISTED
Achilles Therapeutics
ACHL
| $1.31M | 0.08% |
1,608,089
| – | – |
|
60
Standard BioTools
LAB
$329M
| $729K | 0.04% |
411,631
| – | – |
|
|
ADAP
61
DELISTED
Adaptimmune Therapeutics
ADAP
| $698K | 0.04% |
715,607
| – | – |
|
|
HOOK
62
DELISTED
HOOKIPA Pharma
HOOK
| $630K | 0.04% |
106,377
| – | – |
|
63
Alpha Teknova
TKNO
$284M
| $212K | 0.01% |
154,509
-16,944
| -10% | -$32.2K |
|
|
64
Abbott
ABT
$155B
| – | – |
-262,371
| Closed | -$29.8M |
|
|
65
Align Technology
ALGN
$13B
| – | – |
-87,255
| Closed | -$28.6M |
|
|
APLS
66
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-155,000
| Closed | -$9.11M |
|
67
Cigna
CI
$78.8B
| – | – |
-65,435
| Closed | -$23.8M |
|
68
Quest Diagnostics
DGX
$22.3B
| – | – |
-83,849
| Closed | -$11.2M |
|
69
Elanco Animal Health
ELAN
$12.8B
| – | – |
-676,039
| Closed | -$11M |
|
70
Elevance Health
ELV
$84.8B
| – | – |
-31,223
| Closed | -$16.2M |
|
71
Evolent Health
EVH
$660M
| – | – |
-679,172
| Closed | -$22.3M |
|
72
HCA Healthcare
HCA
$84B
| – | – |
-52,487
| Closed | -$17.5M |
|
73
Icon
ICLR
$13.3B
| – | – |
-36,949
| Closed | -$12.4M |
|
74
McKesson
MCK
$93.2B
| – | – |
-20,707
| Closed | -$11.1M |
|
75
Penumbra
PEN
$12.5B
| – | – |
-44,613
| Closed | -$9.96M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO